Catalyst Funds Management Pty LTD Vor Biopharma Inc. Transaction History
Catalyst Funds Management Pty LTD
- $382 Billion
- Q1 2025
A detailed history of Catalyst Funds Management Pty LTD transactions in Vor Biopharma Inc. stock. As of the latest transaction made, Catalyst Funds Management Pty LTD holds 10,764 shares of VOR stock, worth $1,829. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,764Holding current value
$1,829% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding VOR
# of Institutions
46Shares Held
54.1MCall Options Held
0Put Options Held
0-
Ra Capital Management, L.P. Boston, MA39.6MShares$6.74 Million0.59% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA6.36MShares$1.08 Million3.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.94MShares$329,8370.0% of portfolio
-
Johnson & Johnson New Brunswick, NJ1.07MShares$182,6910.26% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny701KShares$119,2430.0% of portfolio
About Vor Biopharma Inc.
- Ticker VOR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,056,300
- Market Cap $6.47M
- Description
- Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...